| 1298492 | BP31_H | Blood pressure QTL 31 (human) | 2.07 | | Blood pressure | systolic | 11 | 34640077 | 123626865 | Human | n/a | region | qtl |
| 2289174 | SADIPOQ7_H | Serum adiponectin level QTL 7 (human) | 4.2 | | Hormone level | adiponectin level | 11 | 58496495 | 120828264 | Human | n/a | region | qtl |
| 1357380 | BW64_H | Body weight QTL 64 (human) | 2.2 | | Body weight | percent fat after exercise training | 11 | 75662287 | 120989875 | Human | n/a | region | qtl |
| 2289454 | BW298_H | Body weight QTL 298 (human) | 3.35 | | Body weight | body mass index | 11 | 79965403 | 123626865 | Human | n/a | region | qtl |
| 1357379 | BW70_H | Body weight QTL 70 (human) | | .0079 | Body weight | body mass index | 11 | 92558848 | 118558848 | Human | n/a | region | qtl |
| 2289196 | BW371_H | Body weight QTL371 (human) | 2.7 | | Body fat amount | percent fat | 11 | 92558848 | 118558848 | Human | n/a | region | qtl |
| 2289206 | BW355_H | Body weight QTL 355 (human) | | .0009 | Body fat amount | percent fat | 11 | 94517717 | 120517717 | Human | n/a | region | qtl |
| 1643269 | SADIPOQ5_H | Serum adiponectin level QTL 5 (human) | 2.89 | | Hormone level | serum adiponectin level | 11 | 98223722 | 124223722 | Human | n/a | region | qtl |
| 2302761 | MAMTS20_H | Mammary tumor susceptibility QTL 20 (human) | | .023 | Mammary tumor susceptibility | | 11 | 98223722 | 124223722 | Human | n/a | region | qtl |
| 2302778 | MAMTS21_H | Mammary tumor susceptibility QTL 21 (human) | | .057 | Mammary tumor susceptibility | | 13 | 98223722 | 124223722 | Human | n/a | region | qtl |
| 1559115 | SCL20_H | Serum cholesterol level QTL 20 (human) | 3.22 | .001213 | Lipid level | LDL cholesterol | 11 | 100313159 | 126313159 | Human | n/a | region | qtl |
| 2293387 | PRSTS275_H | Prostate tumor susceptibility QTL 275 (human) | | | Prostate tumor susceptibility | | 11 | 102287419 | 128287419 | Human | n/a | region | qtl |
| 1298500 | RA19_H | Rheumatoid arthritis QTL 19 (human) | | .0258 | Joint/bone inflammation | rheumatoid arthritis | 11 | 104697838 | 130697838 | Human | n/a | region | qtl |
| 2289605 | BW474_H | Body weight QTL 474 (human) | 1.4 | | Body fat amount | abdominal | 11 | 107828366 | 133828366 | Human | n/a | region | qtl |
| 2314734 | GLUCO83_H | Glucose level QTL 83 (human) | .8 | .041 | Glucose level | non-insulin dependent | 11 | 107828366 | 133828366 | Human | n/a | region | qtl |
| 1559358 | SCL91_H | Serum cholesterol level QTL 91 (human) | 2.03 | .001 | Lipid level | triglyceride | 11 | 109297904 | 134937540 | Human | n/a | region | qtl |
| 1559127 | SCL54_H | Serum cholesterol level QTL 54 (human) | 1.93 | | Lipid level | triglyceride | 11 | 110626746 | 134937540 | Human | n/a | region | qtl |
| 1643285 | SADIPOQ1_H | Serum adiponectin level QTL 1 (human) | 2.33 | | Hormone level | serum adiponectin level | 11 | 110626746 | 134937540 | Human | n/a | region | qtl |
| 1643503 | BW290_H | Body Weight QTL 290 (human) | 2.1 | | Body weight | BMI | 11 | 110626746 | 134937540 | Human | n/a | region | qtl |
| 2292836 | MYI33_H | Myocardial infarction susceptibility QTL 33 (human) | | | Myocardial infarction susceptibility | early-onset | 11 | 110626746 | 134937540 | Human | n/a | region | qtl |
| 2292856 | MYI32_H | Myocardial infarction susceptibility QTL 32 (human) | | | Myocardial infarction susceptibility | early-onset | 11 | 110626746 | 134937540 | Human | n/a | region | qtl |
| 1298513 | BP22_H | Blood pressure QTL 22 (human) | | .004 | Blood pressure | hypertension susceptibility | 11 | 113080426 | 134937540 | Human | n/a | region | qtl |
| 2289548 | BW430_H | Body weight QTL 430 (human) | | | Body weight | BMI | 11 | 113080426 | 134937540 | Human | n/a | region | qtl |
| 1643437 | SLIPL1_H | Serum lipid level QTL 1 (human) | 2.66 | .00023 | Lipid level | | 11 | 115624149 | 134937540 | Human | n/a | region | qtl |
| 1643567 | GLUCO29_H | Glucose level QTL 29 (human) | .71 | .035 | Glucose level | non-insulin-dependent | 11 | 115624149 | 134937540 | Human | n/a | region | qtl |